Neuropilin 1 Protein (NRP1) (AA 22-644) (His tag)
-
- Target See all Neuropilin 1 (NRP1) Proteins
- Neuropilin 1 (NRP1)
- Protein Type
- Recombinant
- Biological Activity
- Active
- Protein Characteristics
- AA 22-644
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This Neuropilin 1 protein is labelled with His tag.
- Sequence
- AA 22-644
- Characteristics
- This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 70.7 kDa. The protein migrates as 85-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
- Purity
- >92 % as determined by SDS-PAGE.
- Sterility
- 0.22 μm filtered
- Endotoxin Level
- Less than 1.0 EU per μg by the LAL method.
- Top Product
- Discover our top product NRP1 Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4
- Handling Advice
- Please avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- No activity loss was observed after storage at: In lyophilized state for 1 year (4 °C), After reconstitution under sterile conditions for 3 months (-70 °C).
-
- Target
- Neuropilin 1 (NRP1)
- Alternative Name
- Neuropilin-1 (NRP1 Products)
- Background
- Neuropilin-1 (NRP1) is also known as Vascular endothelial cell growth factor 165 receptor (VEGF165R), CD antigen CD304, which belongs to the neuropilin family. The membrane-bound isoform 1 is a receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. It mediates the chemorepulsant activity of semaphorins. It binds to semaphorin 3A, The PLGF-2 isoform of PGF, The VEGF-165 isoform of VEGF and VEGF-B. Coexpression with KDR results in increased VEGF-165 binding to KDR as well as increased chemotaxis. It may regulate VEGF-induced angiogenesis. The soluble isoform 2 binds VEGF-165 and appears to inhibit its binding to cells.
- Molecular Weight
- 70.8 kDa
- Pathways
- Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals
-